These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 9382581)

  • 1. Large-scale epidemiological study of the causal agents of onychomycosis: mycological findings from the Multicenter Onychomycosis Study of Terbinafine.
    Elewski BE
    Arch Dermatol; 1997 Oct; 133(10):1317-8. PubMed ID: 9382581
    [No Abstract]   [Full Text] [Related]  

  • 2. Onychomycosis in children: a survey of 46 cases.
    Romano C; Papini M; Ghilardi A; Gianni C
    Mycoses; 2005 Nov; 48(6):430-7. PubMed ID: 16262881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-dermatophytes in onychomycosis of the toenails.
    Ellis DH; Watson AB; Marley JE; Williams TG
    Br J Dermatol; 1997 Apr; 136(4):490-3. PubMed ID: 9155945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: onychomycosis due to Trichophyton schoenleinii.
    Macura AB; Krzyściak P; Skóra M; Gniadek A
    Mycoses; 2012 Mar; 55(2):e18-9. PubMed ID: 21771109
    [No Abstract]   [Full Text] [Related]  

  • 5. [The modern approach to the treatment for onychomycosis of hands and feet in the outpatient setting].
    Gerasimchuk EV; Gerasimov VV; Molchanov BA
    Voen Med Zh; 2005 Nov; 326(11):44-5. PubMed ID: 16404907
    [No Abstract]   [Full Text] [Related]  

  • 6. Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents.
    Baudraz-Rosselet F; Ruffieux C; Lurati M; Bontems O; Monod M
    Dermatology; 2010; 220(2):164-8. PubMed ID: 20110639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terbinafine vs. placebo for onychomycosis in black patients.
    Billstein S; Kianifard F; Justice A
    Int J Dermatol; 1999 May; 38(5):377-9. PubMed ID: 10369551
    [No Abstract]   [Full Text] [Related]  

  • 8. Nondermatophytic onychomycosis by Fusarium oxysporum in an immunocompetent host.
    Shah SR; Dalal BD; Modak MS
    J Mycol Med; 2016 Mar; 26(1):e18-21. PubMed ID: 26852190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail.
    Bradley MC; Leidich S; Isham N; Elewski BE; Ghannoum MA
    Mycoses; 1999; 42 Suppl 2():105-10. PubMed ID: 10865915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study.
    Sigurgeirsson B; Olafsson JH; Steinsson JB; Paul C; Billstein S; Evans EG
    Arch Dermatol; 2002 Mar; 138(3):353-7. PubMed ID: 11902986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of onychomycosis].
    Suhonen R; Karvonen J
    Duodecim; 1998; 22(114):2343-50. PubMed ID: 11757097
    [No Abstract]   [Full Text] [Related]  

  • 12. [Onychomycosis is rare in young children, and treatment is a task for dermatological specialists].
    Haugaard LK; Skov L; Arendrup MC; Saunte DM
    Ugeskr Laeger; 2013 Sep; 175(40):2343-4. PubMed ID: 24079324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terbinafine and onychomycosis.
    Eastcott DF
    N Z Med J; 1991 Jan; 104(904):17. PubMed ID: 1826145
    [No Abstract]   [Full Text] [Related]  

  • 14. Other fungi causing onychomycosis.
    Moreno G; Arenas R
    Clin Dermatol; 2010 Mar; 28(2):160-3. PubMed ID: 20347658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nondermatophytes. Pathogen or distracter in onychomycosis.
    Lagana FJ
    Clin Podiatr Med Surg; 1995 Apr; 12(2):255-62. PubMed ID: 7600499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of lymphocytes subpopulations and natural killer cells in peripheral blood of patients treated for dermatophyte onychomycosis.
    Maleszka R; Adamski Z; Dworacki G
    Mycoses; 2001 Dec; 44(11-12):487-92. PubMed ID: 11820262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onychomycosis due to Onychocola canadensis.
    O'Donoghue NB; Moore MK; Creamer D
    Clin Exp Dermatol; 2003 May; 28(3):283-4. PubMed ID: 12780715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients.
    Ginter-Hanselmayer G; Weger W; Smolle J
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):470-5. PubMed ID: 18194238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot evaluation of pulse itraconazole vs. terbinafine for treatment of Candida toenail onychomycosis.
    Warshaw EM; Nelson D; Carver SM; Zielke GR; Webster N; Lederle FA; Fett DD
    Int J Dermatol; 2005 Sep; 44(9):785-8. PubMed ID: 16135154
    [No Abstract]   [Full Text] [Related]  

  • 20. Continuous terbinafine versus intermittent itraconazole for toenail onychomycosis.
    Warrick D; Church L
    J Fam Pract; 1999 Jul; 48(7):492-3. PubMed ID: 10428238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.